Vitamin Shoppe Inc. (VSI) Trading Down 5.4%
Vitamin Shoppe Inc. (NYSE:VSI) shares dropped 5.4% on Thursday . The company traded as low as $29.74 and last traded at $29.99, with a volume of 191,501 shares traded. The stock had previously closed at $31.70.
VSI has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Vitamin Shoppe from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research report on Tuesday, May 24th. Goldman Sachs Group Inc. lowered shares of Vitamin Shoppe to a “hold” rating in a research report on Saturday, April 30th. Robert W. Baird reissued a “hold” rating on shares of Vitamin Shoppe in a research report on Tuesday, April 26th. Jefferies Group reissued a “hold” rating and set a $32.00 target price (up previously from $30.00) on shares of Vitamin Shoppe in a research report on Friday, May 6th. Finally, Piper Jaffray Cos. reissued a “neutral” rating and set a $30.00 target price on shares of Vitamin Shoppe in a research report on Friday, April 15th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $32.82.
The firm’s 50 day moving average price is $30.81 and its 200-day moving average price is $29.90. The firm has a market cap of $697.30 million and a price-to-earnings ratio of 16.68.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, May 4th. The company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.02. The firm earned $336.80 million during the quarter, compared to analyst estimates of $339.76 million. The business’s revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.63 EPS. Equities analysts expect that Vitamin Shoppe Inc. will post $2.32 EPS for the current year.
In other news, Director Guillermo Marmol purchased 1,000 shares of the business’s stock in a transaction on Tuesday, May 31st. The stock was purchased at an average price of $30.23 per share, for a total transaction of $30,230.00. Following the completion of the purchase, the director now directly owns 1,470 shares in the company, valued at approximately $44,438.10. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Other hedge funds have recently made changes to their positions in the company. Employees Retirement System of Texas purchased a new stake in shares of Vitamin Shoppe during the fourth quarter worth approximately $1,275,000. Rhumbline Advisers boosted its stake in shares of Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock worth $1,475,000 after buying an additional 1,855 shares in the last quarter. Gabelli Funds LLC boosted its stake in shares of Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock worth $1,734,000 after buying an additional 7,000 shares in the last quarter. California State Teachers Retirement System boosted its stake in shares of Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock worth $1,802,000 after buying an additional 885 shares in the last quarter. Finally, State of Wisconsin Investment Board boosted its stake in shares of Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock worth $5,203,000 after buying an additional 1,229 shares in the last quarter.
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.